Trial site
Weill Medical College of Cornell University
- 16running trials
- 14closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Myeloproliferative neoplasms4 trials
- Lung cancer3 trials
- Prostate cancer3 trials
- Alzheimer disease2 trials
- Ovarian cancer2 trials
- Parkinson disease2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Chronic myeloid leukaemia1 trial
- Coronary artery disease1 trial
- and 20 more
- Phase
- Phase 210 trials
- Phase 39 trials
- Phase 13 trials
- Phase 1/23 trials
- Status
- Active, not recruiting9 trials
- Completed9 trials
- Recruiting5 trials
- Withdrawn3 trials
- Not yet recruiting2 trials
- Terminated2 trials
- Suspended1 trial
- Lead sponsor
- Weill Medical College of Cornell University4 trials
- Memorial Sloan Kettering Cancer Center2 trials
- Novo Nordisk A/S2 trials
- PharmaEssentia2 trials
- SWOG Cancer Research Network2 trials
- and 19 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Active, not recruiting
Implementing a Home Blood Pressure Monitoring Program in Primary Care
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
Active, not recruiting
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis1 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Parkinson disease1 recruiting
- Stroke1 recruiting
Closed trials
Withdrawn
Completed
Completed
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Completed
Completed
Terminated
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Withdrawn
Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Completed
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026